Warning Letters
Learn about the types of warning letters on FDA's website.
- Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the letter.
- To obtain additional available information, contact FDA. Requests to FDA for agency records should be sent to: Food and Drug Administration Division of Freedom of Information (HFI-35), 5630 Fishers Lane, Rockville, MD 20857. Instructions for how to submit an FOI request can be found at How to Make a FOIA Request.
Posted Date | Letter Issue Date | Company Name | Issuing Office | Subject | Response Letter | Closeout Letter | Excerpt |
---|---|---|---|---|---|---|---|
RickinmortyBars | Center for Tobacco Products | Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded | |||||
Vape Society Supply | Center for Tobacco Products | Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded | |||||
Del Valle Import & Export 3, Inc. DBA El Progreso Imports | Division of West Coast Imports | Foreign Supplier Verification Program (FSVP) | |||||
Safecor Health, LLC | Division of Pharmaceutical Quality Operations I | CGMP/Finished Pharmaceuticals/Adulterated | |||||
TRP Company, Inc | Center for Drug Evaluation and Research | CDER | Unapproved New Drugs/Misbranded | |||||
Natural Ophthalmics, Inc. | Center for Drug Evaluation and Research | CDER | Unapproved New Drugs/Misbranded | |||||
CVS Health | Center for Drug Evaluation and Research | CDER | Unapproved New Drugs/Misbranded | |||||
Boiron, Inc. | Center for Drug Evaluation and Research | CDER | Unapproved New Drugs/Misbranded |
|||||
DR Vitamins, LLC dba DR Vitamin Solutions | Center for Drug Evaluation and Research | CDER | Unapproved New Drugs/Misbranded | |||||
Similasan AG | Center for Drug Evaluation and Research | CDER | CGMP/Finished Pharmaceuticals/Adulterated/Unapproved New Drug |